GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
51.40
-3.07 (-5.64%)
At close: Apr 29, 2026, 4:00 PM EDT
51.42
+0.02 (0.04%)
After-hours: Apr 29, 2026, 5:12 PM EDT
GSK Employees
GSK plc had 66,841 employees as of December 31, 2025. The number of employees decreased by 1,788 or -2.61% compared to the previous year.
Employees
66,841
Change (1Y)
-1,788
Growth (1Y)
-2.61%
Revenue / Employee
$647,583
Profits / Employee
$115,154
Market Cap
109.34B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 66,841 | -1,788 | -2.61% |
| Dec 31, 2024 | 68,629 | -1,583 | -2.25% |
| Dec 31, 2023 | 70,212 | 812 | 1.17% |
| Dec 31, 2022 | 69,400 | -20,696 | -22.97% |
| Dec 31, 2021 | 90,096 | -3,970 | -4.22% |
| Dec 31, 2020 | 94,066 | -5,371 | -5.40% |
| Dec 31, 2019 | 99,437 | 3,947 | 4.13% |
| Dec 31, 2018 | 95,490 | -2,972 | -3.02% |
| Dec 31, 2017 | 98,462 | -838 | -0.84% |
| Dec 31, 2016 | 99,300 | -1,955 | -1.93% |
| Dec 31, 2015 | 101,255 | 3,334 | 3.40% |
| Dec 31, 2014 | 97,921 | -1,530 | -1.54% |
| Dec 31, 2013 | 99,451 | -37 | -0.04% |
| Dec 31, 2012 | 99,488 | 2,099 | 2.16% |
| Dec 31, 2011 | 97,389 | 928 | 0.96% |
| Dec 31, 2010 | 96,461 | -3,452 | -3.46% |
| Dec 31, 2009 | 99,913 | 910 | 0.92% |
| Dec 31, 2008 | 99,003 | -4,480 | -4.33% |
| Dec 31, 2007 | 103,483 | 788 | 0.77% |
| Dec 31, 2006 | 102,695 | 1,967 | 1.95% |
| Dec 31, 2005 | 100,728 | 709 | 0.71% |
| Dec 31, 2004 | 100,019 | -900 | -0.89% |
| Dec 31, 2003 | 100,919 | -3,580 | -3.43% |
| Dec 31, 2002 | 104,499 | -2,971 | -2.76% |
| Dec 31, 2001 | 107,470 | -47 | -0.04% |
| Dec 31, 2000 | 107,517 | -1,524 | -1.40% |
| Dec 31, 1999 | 109,041 | -7,780 | -6.66% |
| Dec 31, 1998 | 116,821 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Pfizer | 75,000 |
| Merck & Co. | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 69,505 |
| AbbVie | 57,000 |
| Bristol-Myers Squibb Company | 32,500 |
GSK News
- 5 hours ago - FTSE 100 closes lower as drugs firms GSK and AstraZeneca struggle - Evening Standard
- 5 hours ago - AstraZeneca (AZN) and GSK Report Strong Q1 Earnings Amid Pricing Policy Concerns - GuruFocus
- 9 hours ago - GSK Reports Strong Q1 2026 Results with Revenue Growth - GuruFocus
- 9 hours ago - GSK Declares Quarterly Dividend of $0.44, Initiates £2 Billion Buyback - GuruFocus
- 9 hours ago - GSK Raises 2031 Sales Forecast to Over GBP 40 Billion - GuruFocus
- 9 hours ago - GSK Expects Steady Growth Through 2026 - GuruFocus
- 9 hours ago - GSK Reports Strong Q1 Sales Growth and Advancements in R&D - GuruFocus
- 9 hours ago - AstraZeneca (AZN) and GlaxoSmithKline (GSK) Exceed Q1 Earnings Expectations - GuruFocus